Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short single-strand snippets of DNA that can target molecules like larger antibodies do -- not only deliver cancer-fighting drugs, but also are themselves toxic to the cancer stem cells, the researchers said.

Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The particles can be targeted directly to tumors, where they release their payload while avoiding many of the side effects of traditional chemotherapy.

While medical centers use ultrasound daily, so far this technology has not been capable of observing body tissues at the scale of cells. Physicists have now developed a microscopy technique based on ultrasound to reveal capillaries and cells across living organs -- something that wasn't possible before.

Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug cisplatin. Recently, the search for alternatives with improved activity has begun to focus on gold. A research team has now published a study about the speciation and distribution of an organogold(III) complex in cancer cells and reveals how specially designed 'organogold' complexes might open exciting avenues for fighting cancer.

Obesity is at epidemic proportions in the United States where more than 40% of adults are obese and more than 70% are overweight. One common policy intervention to tackle this urgent issue is to try to improve diet quality by increasing local grocery stores that offer healthy options. However, this is not a silver bullet, but researchers are not sure why. A team of researchers developed a novel tool to help understand consumer behavior at the county level, and to study the relationship between where people shop for their food and the risk of obesity-related cancers.

Scientists are working to create a new light-activated 'smart' bomb to treat aggressive breast cancer. The new light-sensitive chemicals called cyanine-carborane salts are used in photodynamic therapy, or PDT, to destroy metastatic breast cancer tumors in mice with minimal side effects.